Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoring

MeSH terms

• Antiviral Agents* / pharmacology
• Antiviral Agents* / therapeutic use
• Drug Resistance, Viral* / genetics
• Enzyme Inhibitors / pharmacology
• Enzyme Inhibitors / therapeutic use
• Humans
• Influenza A Virus, H1N1 Subtype* / drug effects
• Influenza A Virus, H1N1 Subtype* / genetics
• Influenza, Human* / drug therapy
• Influenza, Human* / virology
• Mutation*
• Neuraminidase* / antagonists & inhibitors
• Neuraminidase* / genetics
• Oseltamivir / pharmacology
• Oseltamivir / therapeutic use
• Viral Proteins / genetics